Literature DB >> 27481423

Sustained Acid Suppression by Potassium-Competitive Acid Blocker (P-CAB) May Be An Attractive Treatment Candidate for Patients with Eosinophilic Esophagitis.

Norihisa Ishimura1, Shunji Ishihara1, Yoshikazu Kinoshita1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27481423     DOI： 10.1038/ajg.2016.167

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects--a randomised open-label cross-over study.

Authors:  Y Sakurai; Y Mori; H Okamoto; A Nishimura; E Komura; T Araki; M Shiramoto
Journal:  Aliment Pharmacol Ther       Date:  2015-07-21       Impact factor: 8.171

2.  Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis.

Authors:  Javier Molina-Infante; Joaquin Rodriguez-Sanchez; Jan Martinek; Bram D van Rhijn; Jana Krajciova; Maria D Rivas; Jesus Barrio; Fouad J Moawad; Carmen Martinez-Alcalá; Albert J Bredenoord; Jose Zamorano; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

Review 3.  Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis.

Authors:  Alfredo J Lucendo; Ángel Arias; Javier Molina-Infante
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-03       Impact factor: 11.382

4.  Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.

Authors:  Edaire Cheng; Xi Zhang; Xiaofang Huo; Chunhua Yu; Qiuyang Zhang; David H Wang; Stuart Jon Spechler; Rhonda F Souza
Journal:  Gut       Date:  2012-05-12       Impact factor: 23.059

5.  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects.

Authors:  Yuuichi Sakurai; Akira Nishimura; Gale Kennedy; Mark Hibberd; Richard Jenkins; Hiroyuki Okamoto; Tomoki Yoneyama; Helen Jenkins; Kiyoshi Ashida; Shin Irie; Jörg Täubel
Journal:  Clin Transl Gastroenterol       Date:  2015-06-25       Impact factor: 4.488

6.  Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?

Authors:  Richard H Hunt; Carmelo Scarpignato
Journal:  Clin Transl Gastroenterol       Date:  2015-10-29       Impact factor: 4.488
  6 in total
  8 in total

1.  Response to Ishimura et al.

Authors:  Javier Molina-Infante; Alfredo J Lucendo; Jose Zamorano
Journal:  Am J Gastroenterol       Date:  2016-08       Impact factor: 10.864

2.  Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: A Paradigm Shift.

Authors:  Javier Molina-Infante; Alfredo J Lucendo
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

Review 3.  Management of refractory eosinophilic oesophagitis.

Authors:  Evan S Dellon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-24       Impact factor: 46.802

4.  Clinical Manifestations of Eosinophilic Esophagitis in Children and Adolescents: A Single-Center, Matched Case-Control Study.

Authors:  Ji Hyeon Roh; Eell Ryoo; Hann Tchah
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-07-03

Review 5.  Recent advances in eosinophilic esophagitis.

Authors:  Sandy Durrani; Marc Rothenberg
Journal:  F1000Res       Date:  2017-09-28

Review 6.  Symptom-based diagnostic approach for eosinophilic esophagitis.

Authors:  Yasuhiro Fujiwara
Journal:  J Gastroenterol       Date:  2020-07-27       Impact factor: 7.527

Review 7.  Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date.

Authors:  Kentaro Sugano
Journal:  Therap Adv Gastroenterol       Date:  2018-01-09       Impact factor: 4.409

Review 8.  The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis.

Authors:  Carolina Gutiérrez-Junquera; Sonia Fernández-Fernández; M Luz Cilleruelo; Ana Rayo; Enriqueta Román
Journal:  Front Pediatr       Date:  2018-05-08       Impact factor: 3.418
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.